Factors Associated With Chronic Hepatitis in Patients With Hepatitis E Virus Infection Who Have Received Solid Organ Transplants

Nassim Kamar, Cyril Garrouste, Elizabeth B. Haagsma, +18

Gastroenterology

TransplantationHepatologyViral HepatitisChronic HepatitisSolid Organ Transplantation +4

A Mutation in the Hepatitis E Virus RNA Polymerase Promotes Its Replication and Associates With Ribavirin Treatment Failure in Organ Transplant Recipients

Yannick Debing, A. Gisa, Kai Dallmeier, +6

Gastroenterology

Viral ReplicationTransplantationHepatologyRibavirin Treatment FailureViral Hepatitis +8

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

Sven Pischke, Pothakamuri Venkata Suneetha, Christine Baechlein, +17

Liver Transplantation

Ribavirin treatment of acute and chronic hepatitis E: a single‐centre experience

Sven Pischke, Svenja Hardtke, Ulrike Bode, +7

Liver International

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

Daniel Tödt, A. Gisa, Aleksandar Radonić, +11

Gut

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

Pothakamuri Venkata Suneetha, Sven Pischke, Verena Schlaphoff, +10

Hepatology

Adaptive Immune SystemImmunologyCd4 T Cell ResponsesHev InfectionImmunotherapy +15

The Molecular and Cellular Identity of Peripheral Osmoreceptors

Stefan G. Lechner, Sören Markworth, Kate Poole, +10

Neuron

Photoreceptor CellSignal TransductionMolecular PhysiologyPhysiologyCellular Identity +6

Chronic Hepatitis E in Heart Transplant Recipients

Sven Pischke, Penelope Stiefel, B Franz, +14

American Journal of Transplantation

Heart FailureTransplantationHepatologyHepatitisLiver Transplantation +4

Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation

Lena Allweiss, S Gass, Katja Giersch, +11

Journal of Hepatology

Translational MedicineHepatologyNew ModelPreclinical Drug EvaluationViral Hepatitis +12

HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients

Dirk Westhölter, Jens Hiller, U Denzer, +14

Journal of Hepatology

VaccinationMedicineVirologyHev-positive Blood DonationsRelevant Infection Risk +5